Literature DB >> 1612574

Radiation therapy for nasopharyngeal carcinoma: histologic appearances and patterns of tumor regression.

J M Nicholls1, J Sham, C W Chan, D Choy.   

Abstract

Nasopharyngeal carcinoma is a common malignancy in Hong Kong and is treated by external radiotherapy. After 6.5 weeks of radiotherapy, the nasopharynx of 100 patients was examined and biopsy specimens were taken. All patients had repeated examination and biopsies done every 2 weeks until exophytic tumor was not seen and biopsy samples were negative on more than one examination of the nasopharynx. The interval between the cessation of therapy and biopsy ranged from 1 day to 11 weeks. Twenty-three patients had atypical findings and five of these had residual tumor requiring gold grain implantation brachytherapy. We identified a number of distinct pathologic changes in the post-biopsy material. Most of these changes disappeared 8 weeks after the cessation of therapy, but the presence of residual tumor after this time was an indication for subsequent therapy. If the date of the first biopsy was delayed until 6 weeks after the completion of radiotherapy, the percentage of atypical biopsies containing residual tumor rose from 21% to 55%. The posttreatment biopsy should be performed twice, as four patients had negative biopsy findings due to sampling error.

Entities:  

Mesh:

Year:  1992        PMID: 1612574     DOI: 10.1016/0046-8177(92)90342-z

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

Review 1.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

2.  Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma.

Authors:  C W Chan; J M Nicholls; J S Sham; P Dickens; D Choy
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

3.  Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.

Authors:  Victor Ho-Fun Lee; Dora Lai-Wan Kwong; To-Wai Leung; Cheuk-Wai Choi; Vincent Lai; Lydia Ng; Ka-On Lam; Sherry Chor-Yi Ng; Chun-Kin Sze; Chi-Chung Tong; Patty Pui-Ying Ho; Wing-Lok Chan; Lai-San Wong; Dennis Kwok-Chuen Leung; Sum-Yin Chan; Pek-Lan Khong
Journal:  Oncotarget       Date:  2017-01-17

4.  The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.

Authors:  Katelyn O Stepan; Angela L Mazul; S Andrew Skillington; Randal C Paniello; Jason T Rich; Jose P Zevallos; Ryan S Jackson; Patrik Pipkorn; Sean Massa; Sidharth V Puram
Journal:  Head Neck       Date:  2021-02-23       Impact factor: 3.821

5.  A Nomogram for the Prognosis of Nasopharyngeal Carcinoma with MR Imaging-Detected Tumor Residue at the End of Intensity-Modulated Radiotherapy.

Authors:  Meng Xu; Chang Liu; Jing Lin Mi; Ren Sheng Wang
Journal:  Cancer Manag Res       Date:  2020-05-25       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.